EVGN
Evogene
NASDAQ: EVGN · HEALTHCARE · BIOTECHNOLOGY
$0.78
+2.88% today
Updated 2026-04-30
Market cap
$9.54M
P/E ratio
—
P/S ratio
2.48x
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
Evogene (EVGN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.90M | $17.07M | $17.58M | $14.51M | $11.13M | $6.54M | $3.38M | $1.75M | $753000.00 | $1.04M | $930000.00 | $1.68M | $5.64M | $8.51M | $3.85M |
| Revenue growth (YoY) | — | +14.6% | +3.0% | -17.5% | -23.3% | -41.2% | -48.3% | -48.3% | -56.9% | +38.1% | -10.6% | +80.1% | +236.7% | +50.9% | -54.7% |
| Cost of revenue | $9.14M | $10.47M | $11.14M | $10.96M | $9.73M | $7.32M | $4.68M | $3.31M | $3.10M | $3.30M | $3.00M | $3.45M | $4.24M | $5.12M | $3.06M |
| Gross profit | $5.76M | $6.60M | $6.44M | $3.55M | $1.40M | $-778000.00 | $-1.30M | $-1.56M | $-2.35M | $-2.26M | $-2.07M | $-1.77M | $1.40M | $3.39M | $795000.00 |
| Gross margin | 38.7% | 38.6% | 36.6% | 24.5% | 12.6% | -11.9% | -38.5% | -89.5% | -312.1% | -217.4% | -222.7% | -105.9% | 24.8% | 39.8% | 20.6% |
| R&D | $6.63M | $7.49M | $11.59M | $14.62M | $14.94M | $16.42M | $14.99M | $14.09M | $14.62M | $16.60M | $19.43M | $17.53M | $18.11M | $14.26M | $7.99M |
| SG&A | $3.45M | $3.39M | $3.56M | $4.18M | $4.38M | $3.89M | $3.81M | $3.51M | $3.77M | $5.32M | $9.34M | $9.40M | $8.67M | $10.04M | $5.76M |
| Operating income | $-3.18M | $-3.16M | $-8.72M | $-15.26M | $-17.92M | $-21.09M | $-21.79M | $-21.25M | $-22.74M | $-26.84M | $-31.49M | $-29.71M | $-26.39M | $-21.73M | $-14.00M |
| Operating margin | -21.3% | -18.5% | -49.6% | -105.1% | -161.0% | -322.5% | -644.3% | -1216.6% | -3019.9% | -2580.3% | -3386.0% | -1774.0% | -467.9% | -255.4% | -363.3% |
| EBITDA | $2.07M | $-524000.00 | $-6.75M | $-12.08M | $-14.58M | $-17.12M | $-18.55M | $-18.62M | $-15.97M | $-23.18M | $-27.80M | $-26.93M | $-23.20M | $-15.38M | $-12.85M |
| EBITDA margin | 13.9% | -3.1% | -38.4% | -83.3% | -131.0% | -261.8% | -548.7% | -1065.9% | -2120.6% | -2228.7% | -2988.7% | -1607.9% | -411.4% | -180.7% | -333.6% |
| EBIT | $652000.00 | $-2.36M | $-8.79M | $-14.33M | $-17.02M | $-19.40M | $-20.70M | $-20.64M | $-18.74M | $-25.91M | $-30.03M | $-29.51M | $-25.82M | $-17.88M | $-14.00M |
| Interest expense | $7000.00 | $89000.00 | $87000.00 | $200000.00 | $195000.00 | $155000.00 | $129000.00 | $141000.00 | $354000.00 | $269000.00 | $403000.00 | $241000.00 | $171000.00 | $124000.00 | $1.89M |
| Income tax | $-3.83M | $74000.00 | $-1.67M | $-1.80M | $-2.20M | $36000.00 | $11000.00 | $30000.00 | $24000.00 | $32000.00 | $13000.00 | $90000.00 | $-33000.00 | $9000.00 | — |
| Effective tax rate | 120.3% | -3.0% | 15.8% | 11.0% | 11.3% | -0.2% | -0.1% | -0.1% | -0.1% | -0.1% | -0.0% | -0.3% | 0.1% | -0.1% | 0.0% |
| Net income | $645000.00 | $-2.52M | $-8.88M | $-14.53M | $-17.21M | $-19.59M | $-20.84M | $-20.76M | $-18.11M | $-23.37M | $-27.79M | $-26.64M | $-23.88M | $-16.48M | $-8.48M |
| Net income growth (YoY) | — | -491.0% | -252.0% | -63.7% | -18.5% | -13.8% | -6.4% | +0.4% | +12.7% | -29.1% | -18.9% | +4.2% | +10.4% | +31.0% | +48.5% |
| Profit margin | 4.3% | -14.8% | -50.5% | -100.1% | -154.7% | -299.6% | -616.3% | -1188.2% | -2405.3% | -2247.5% | -2988.5% | -1590.3% | -423.4% | -193.7% | -220.2% |